2. Dobner J, Kaser S. Body mass index and the risk of infection: from underweight to obesity. Clin Microbiol Infect 2018;24:24-8.
[PUBMED]
3. Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Moller BK, et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology 2015;26:580-9.
[PUBMED]
4. Maccioni L, Weber S, Elgizouli M, Stoehlker AS, Geist I, Peter HH, et al. Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health 2018;18:271.
[CROSSREF] [PUBMED] [PMC]
6. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean Society for the Study of Obesity guideline for the management of obesity in Korea. J Obes Metab Syndr 2019;28:40-5.
[CROSSREF] [PUBMED] [PMC]
7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
[CROSSREF] [PUBMED]
8. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev 2020;21:e13128.
[CROSSREF]
9. Wang J, Zhu L, Liu L, Zhao XA, Zhang Z, Xue L, et al. Overweight and obesity are risk factors of severe illness in patients with COVID-19. Obesity (Silver Spring) 2020;28:2049-55.
[CROSSREF] [PUBMED]
10. Singh S, Bilal M, Pakhchanian H, Raiker R, Kochhar GS, Thompson CC. Impact of obesity on outcomes of patients with coronavirus disease 2019 in the United States: a multicenter electronic health records network study. Gastroenterology 2020;159:2221-5.
[CROSSREF] [PUBMED] [PMC]
11. Hamer M, Gale CR, Kivimaki M, Batty GD. Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A 2020;117:21011-3.
[CROSSREF] [PUBMED] [PMC]
12. Czernichow S, Beeker N, Rives-Lange C, Guerot E, Diehl JL, Katsahian S, et al. Obesity doubles mortality in patients hospitalized for severe acute respiratory syndrome coronavirus 2 in Paris hospitals, France: a cohort study on 5,795 patients. Obesity (Silver Spring) 2020;28:2282-9.
[CROSSREF]
13. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc 2020;95:1445-53.
[CROSSREF] [PUBMED] [PMC]
14. Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhaes KG. Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID-19 patients with obesity. Front Endocrinol (Lausanne) 2020;11:530.
[PUBMED] [PMC]
15. Cinti S, Graciotti L, Giordano A, Valerio A, Nisoli E. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity. Int J Obes (Lond) 2020;44:1800-2.
[CROSSREF] [PUBMED]
16. Lubrano C, Masi D, Risi R, Balena A, Watanabe M, Mariani S, et al. Is growth hormone insufficiency the missing link between obesity, male gender, age, and COVID-19 severity? Obesity (Silver Spring) 2020;28:2038-9.
[CROSSREF] [PUBMED]
17. Rapp JL, Lieberman-Cribbin W, Tuminello S, Taioli E. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City. Chest 2021;159:112-5.
[CROSSREF] [PUBMED]
18. Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, et al. Obesity as a potential predictor of disease severity in young COVID-19 patients: a retrospective study. Obesity (Silver Spring) 2020;28:1815-25.
[CROSSREF] [PUBMED]